Pulse Biosciences Analyst Ratings
Pulse Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/21/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 05/13/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 04/01/2022 | 763.31% | Stephens & Co. | $14 → $12 | Maintains | Overweight |
| 04/01/2022 | 511.51% | HC Wainwright & Co. | $20 → $8.5 | Maintains | Buy |
| 02/10/2022 | 1338.85% | HC Wainwright & Co. | $43 → $20 | Maintains | Buy |
| 11/16/2021 | 2993.53% | HC Wainwright & Co. | $46 → $43 | Maintains | Buy |
| 07/27/2021 | 1914.39% | Stephens & Co. | → $28 | Initiates Coverage On | → Overweight |
| 03/11/2021 | 2777.7% | Maxim Group | → $40 | Initiates Coverage On | → Buy |
| 01/26/2021 | 2777.7% | HC Wainwright & Co. | $16 → $40 | Maintains | Buy |
| 05/12/2020 | 1051.08% | HC Wainwright & Co. | $6 → $16 | Upgrades | Neutral → Buy |
| 02/14/2020 | 331.65% | HC Wainwright & Co. | → $6 | Downgrades | Buy → Neutral |
| 02/25/2019 | — | HC Wainwright & Co. | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 09/21/2022 | — | Maxim 集團 | 降級 | 買入 → 持有 | |
| 05/13/2022 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 04/01/2022 | 763.31% | Stephens & Co. | 14 美元 → 12 美元 | 維護 | 超重 |
| 04/01/2022 | 511.51% | HC Wainwright & Co. | 20 美元 → 8.5 美元 | 維護 | 買 |
| 02/10/2022 | 1338.85% | HC Wainwright & Co. | 43 美元 → 20 美元 | 維護 | 買 |
| 11/16/2021 | 2993.53% | HC Wainwright & Co. | 46 美元 → 43 美元 | 維護 | 買 |
| 2021 年 7 月 27 日 | 1914.39% | Stephens & Co. | → 28 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 03/11/2021 | 2777.7% | Maxim 集團 | → 40 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2021 年 1 月 26 日 | 2777.7% | HC Wainwright & Co. | 16 美元 → 40 美元 | 維護 | 買 |
| 05/12/2020 | 1051.08% | HC Wainwright & Co. | 6 美元 → 16 美元 | 升級 | 中性 → 買入 |
| 02/14/2020 | 331.65% | HC Wainwright & Co. | → 6 美元 | 降級 | 買入 → 中性 |
| 02/25/2019 | — | HC Wainwright & Co. | 啓動覆蓋範圍開啓 | → 購買 |
Pulse Biosciences Questions & Answers
脈衝生物科學問題與解答
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on September 21, 2022. The analyst firm set a price target for $0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
Maxim集團於2022年9月21日公佈了Pulse Biosciences（納斯達克股票代碼：PLSE）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計PLSE將在12個月內跌至12個月內（可能下跌-100.00％）。去年有6家分析公司公佈了評級。
The latest analyst rating for Pulse Biosciences (NASDAQ: PLSE) was provided by Maxim Group, and Pulse Biosciences downgraded their hold rating.
Pulse Biosciences（納斯達克股票代碼：PLSE）的最新分析師評級由Maxim集團提供，Pulse Biosciences下調了持有評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pulse Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pulse Biosciences was filed on September 21, 2022 so you should expect the next rating to be made available sometime around September 21, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Pulse Biosciences的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Pulse Biosciences的最新評級是在2022年9月21日公佈的，因此您應該預計下一個評級將在2023年9月21日左右公佈。
While ratings are subjective and will change, the latest Pulse Biosciences (PLSE) rating was a downgraded with a price target of $0.00 to $0.00. The current price Pulse Biosciences (PLSE) is trading at is $1.39, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Pulse Biosciences（PLSE）評級已下調，目標股價爲0.00美元至0.00美元。Pulse Biosciences（PLSE）目前的交易價格爲1.39美元，超出了分析師的預期區間。